English | Español

Abbvie
Amanda Rupp | May 21, 2016

AbbVie, Boehringer to present promising data for Crohn’s research
Amanda Rupp | May 12, 2016

FDA broadens Imbruvica label for CLL, SLL patients
Amanda Rupp | May 4, 2016

AbbVie attains Stemcentrx compound to treat lung cancer
Amanda Rupp | May 1, 2016

Bococizumab SPIRE-2 study completes enrollment process
Amanda Rupp | Apr 29, 2016

AbbVie earns FDA approval for Viekira Pak
Amanda Rupp | Apr 17, 2016

AbbVie releases positive results from hepatitis C treatment tests
Amanda Rupp | Apr 15, 2016

FDA speeds approval of AbbVie's Venclexta tablets for leukemia patients
Amanda Rupp | Apr 7, 2016

AbbVie works to raise awareness for patients with EPI

Trending
+ Pharmaceuticals
Patient Daily | May 28, 2025

University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
+ Pharmaceuticals
Patient Daily | May 29, 2025

Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+ Pharmaceuticals
Patient Daily | May 27, 2025

New study shows effectiveness of recent RSV prevention strategies
+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements